As such, IL-2 seems to be a protective rather than pro-inflammatory cytokine that could be involved in the downregulation of chronic inflammation related to RA progression by shifting the balance from Th17-mediated inflammatory conditions to a Treg-mediated tolerant state. The gene discussed is IL2; the disease is rheumatoid arthritis.